AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Elemental impurity risk management can help biomanufacturers to maintain regulatory alignment and ensure patient safety.

Many business owners view background checks as an unnecessary expense, but the price is minimal compared to the legal and ...

Fans see the 2019 episode as the perfect explainer of the current geopolitical situation, helping to drive a resurgence of ...

LOS ANGELES - As I've written in several columns in the Current and in CityWatch LA, the City, County, and LAHSA tend to use ...

Information, steps and you may technique for to play Queen of one’s individual Nile Didi didn’t remain Charlie’s investing ...

YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and ...

The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible ...

Grifols has filed for US approval of a new drug for rare bleeding disorder acquired fibrinogen deficiency (AFD), which promises to provide a more reliable and easier treatment for patients. The US ...

Eisai has filed for approval in Japan for tasurgratinib, its small-molecule fibroblast growth factor (FGF) receptor inhibitor, as a treatment for biliary tract cancers with FGFR2 gene fusion mutations ...

Driven by rapid clinical translation, industrial-scale allogeneic production, and sustained public–private investment, the ...

Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...